Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.
The chart shows the growth of an initial investment of $10,000 in Acadia Healthcare Company, Inc., comparing it to the performance of the S&P 500 index.
All prices have been adjusted for splits and dividends.
Acadia Healthcare Company, Inc. (ACHC) has returned 67.55% so far this year and -9.10% over the past 12 months. Looking at the last ten years, ACHC has achieved an annualized return of -7.94%, underperforming the Benchmark (SPY), which averaged 12.23% per year.
The table below presents the monthly returns of Acadia Healthcare Company, Inc. (ACHC) with color gradation from worst to best to easily spot seasonal factors.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -6.01% | 75.06% | 0.56% | 2.44% | ||||||||
| 2025 | 13.06% | -32.10% | -0.46% | -23.13% | -3.17% | 0.62% | -4.05% | 5.90% | 9.03% | -12.74% | -19.81% | -17.07% |
| 2024 | 6.72% | 1.34% | -5.44% | -6.85% | -7.09% | -2.29% | -3.97% | 18.29% | -18.81% | -32.23% | -4.53% | -2.60% |
| 2023 | 1.25% | -13.34% | -0.18% | -0.52% | -2.44% | 12.96% | -0.11% | -2.22% | -9.05% | 5.79% | -0.31% | 6.93% |
| 2022 | -13.56% | 7.53% | 9.77% | 3.18% | 4.86% | -5.73% | 23.12% | -1.74% | -4.03% | 2.42% | 7.90% | -7.69% |
| 2021 | 0.68% | 8.08% | 2.03% | 6.84% | 3.62% | -2.71% | -2.02% | 6.83% | -3.80% | -5.33% | -9.04% | 6.66% |
| 2020 | -3.86% | -8.67% | -38.44% | 42.16% | 24.83% | -12.44% | 18.72% | 3.34% | -0.82% | 20.93% | 19.07% | 16.67% |
| 2019 | 7.63% | -4.40% | 11.11% | 8.58% | -3.62% | 8.34% | -9.24% | -16.74% | 18.35% | -2.98% | 6.74% | 3.52% |
| 2018 | 4.32% | 12.49% | 3.13% | -8.20% | 12.58% | 1.26% | -3.02% | 5.78% | -15.57% | 17.10% | -21.76% | -25.76% |
| 2017 | 14.64% | 15.53% | -3.20% | 0.39% | -4.99% | 18.28% | 6.97% | -11.33% | 1.70% | -34.39% | 1.60% | 2.77% |
| 2016 | 15.33% | -7.55% | -5.89% | 1.40% | -8.57% | -3.66% | -27.00% | 4.19% | -13.46% |
The charts below present risk-adjusted performance metrics for Acadia Healthcare Company, Inc. (ACHC) and compare them to a Benchmark (SPY). These indicators evaluate an investment's returns against its associated risks.
The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.
These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns.
The chart below shows the rolling Sharpe ratio of ACHC compared to the benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.
The current Acadia Healthcare Company, Inc. volatility is 3.01%, representing the standart deviation of percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
The Drawdowns chart displays portfolio losses from any high point along the way. It shows the maximum percentage drop from a peak to a trough over a specified period, indicating the risk of significant losses.
Although chart shows positive values, it represents the percentage drop from the peak, so a value of 10% means the portfolio has dropped 10% from its highest point.
The income statement provides a summary of a company's revenues, expenses, and profits over a specific period. It shows how much money the company earned (revenues) and how much it spent (expenses), leading to the net income or profit. This statement is crucial for understanding a company's financial performance and profitability.
| 2025 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities And Equity (USD) | 5.53B | 5.36B | 4.99B | 4.77B | 6.50B | 6.88B | 6.17B | 6.42B | 6.02B | 4.28B | 2.22B | 1.22B | 983.41M | 413.00M |
| Temporary Equity (USD) | 191.59M | 105.69M | 88.26M | 65.39M | 55.32M | 33.15M | 28.81M | 22.42M | 17.75M | 8.06M | - | - | - | - |
| Equity Attributable To Parent (USD) | 1.95B | 2.78B | 2.81B | 2.52B | 1.90B | 2.51B | 2.33B | 2.57B | 2.17B | 1.68B | 880.97M | 480.71M | 432.55M | 96.37M |
| Equity Attributable To Noncontrolling Interest (USD) | - | - | - | - | - | - | - | 22.42M | - | - | - | - | - | - |
| Equity (USD) | 1.95B | 2.78B | 2.81B | 2.52B | 1.90B | 2.51B | 2.33B | 2.60B | 2.17B | 1.68B | 880.97M | 480.71M | 432.55M | 96.37M |
| Redeemable Noncontrolling Interest (USD) | 191.59M | 105.69M | 88.26M | 65.39M | 55.32M | 33.15M | 28.81M | 22.42M | 17.75M | 8.06M | - | - | - | - |
| Other Non-current Liabilities (USD) | 361.74M | 213.63M | 312.80M | 283.12M | 113.98M | 727.94M | 200.53M | 211.94M | 208.57M | 57.18M | 80.42M | 12.12M | 5.69M | - |
| Long-term Debt (USD) | 2.50B | 1.37B | 1.39B | 1.50B | 3.12B | 3.15B | 3.19B | 3.24B | 3.29B | 2.24B | 1.10B | 617.14M | 473.32M | - |
| Noncurrent Liabilities (USD) | 2.86B | 1.59B | 1.70B | 1.78B | 3.24B | 3.88B | 3.39B | 3.45B | 3.50B | 2.30B | 1.18B | 629.26M | 479.01M | 275.96M |
| Other Current Liabilities (USD) | 186.15M | 587.75M | 158.31M | 168.44M | 1.10B | 213.98M | 185.34M | 176.04M | 157.76M | 118.17M | 57.92M | 40.94M | 24.02M | 15.83M |
| Wages (USD) | 188.64M | 141.90M | 125.30M | 137.85M | 124.91M | 122.55M | 113.30M | 99.05M | 105.07M | 80.70M | 59.32M | 37.72M | 28.75M | 16.20M |
| Accounts Payable (USD) | 150.40M | 156.13M | 104.72M | 98.58M | 87.82M | 127.05M | 117.74M | 102.30M | 80.03M | 91.34M | 48.70M | 36.03M | 19.08M | 8.64M |
| Current Liabilities (USD) | 525.19M | 885.78M | 388.33M | 404.86M | 1.31B | 463.58M | 416.38M | 377.39M | 342.87M | 290.20M | 165.93M | 114.69M | 71.85M | 40.67M |
| Liabilities (USD) | 3.39B | 2.47B | 2.09B | 2.19B | 4.54B | 4.34B | 3.81B | 3.83B | 3.84B | 2.59B | 1.34B | 743.95M | 550.86M | 316.63M |
| Other Non-current Assets (USD) | 1.51B | 2.42B | 2.45B | 2.43B | 2.28B | 3.02B | 2.53B | 2.82B | 2.81B | 2.22B | 858.11M | 688.86M | 589.50M | 209.19M |
| Intangible Assets (USD) | 96.67M | 73.28M | 76.04M | 70.15M | 68.54M | 90.36M | 88.99M | 87.35M | 83.31M | 59.58M | 21.64M | 20.57M | 15.99M | 8.23M |
| Fixed Assets (USD) | 3.11B | 2.27B | 1.95B | 1.77B | 1.62B | 3.22B | 3.11B | 3.05B | 2.70B | 1.71B | 1.07B | 370.11M | 236.94M | 82.97M |
| Noncurrent Assets (USD) | 4.71B | 4.76B | 4.48B | 4.27B | 3.98B | 6.34B | 5.72B | 5.95B | 5.60B | 3.98B | 1.95B | 1.08B | 842.43M | 300.39M |
| Other Current Assets (USD) | 761.44M | 554.62M | 473.99M | 467.95M | 2.50B | 513.74M | 414.56M | 439.44M | 395.84M | 268.24M | 262.40M | 138.73M | 137.47M | - |
| Prepaid Expenses (USD) | 47.02M | 36.09M | 27.05M | 22.29M | 19.48M | 23.71M | 30.80M | 27.32M | 27.46M | 21.82M | 11.75M | 6.40M | 3.51M | - |
| Inventory (USD) | 5.69M | 5.30M | 5.09M | 4.79M | 4.85M | 4.76M | 5.06M | 4.79M | 4.63M | 4.68M | - | - | - | - |
| Current Assets (USD) | 814.14M | 596.00M | 506.13M | 495.03M | 2.52B | 542.21M | 450.42M | 471.55M | 427.93M | 294.74M | 274.14M | 145.13M | 140.98M | 112.61M |
| Assets (USD) | 5.53B | 5.36B | 4.99B | 4.77B | 6.50B | 6.88B | 6.17B | 6.42B | 6.02B | 4.28B | 2.22B | 1.22B | 983.41M | 413.00M |
Canyon Capital Advisors fully exited its $13 million position in Acadia Healthcare by selling 521,774 shares in Q4 2025. The behavioral healthcare company's stock has declined 22% over the past year, underperforming the S&P 500. While revenue grew 5-6%, the company faced a $996.2 million goodwill impairment and elevated net leverage of 4.0x adjusted EBITDA, signaling operational challenges and financial pressure.
Markets rallied on Wednesday with risk appetite returning as investors positioned ahead of Nvidia's earnings report. The Nasdaq 100 climbed 1.2%, S&P 500 rose 0.7%, and Bitcoin jumped 7%. Tech and software stocks led gains, while energy and consumer staples lagged. Notable earnings movers included strong performances from Circle Internet Group, CAVA Group, and Everus Construction Group, while GoDaddy, First Solar, and CoStar Group declined.
Wall Street declined sharply on Tuesday following President Trump's aggressive trade threats toward Europe, with potential tariffs reaching 25% or higher. The S&P 500 fell 1.5%, Nasdaq 100 dropped 1.4%, and Treasury yields climbed to 5-month highs. Safe-haven assets like gold and silver surged, while Bitcoin fell below $90,000. Most major earnings beat estimates but investor sentiment remained cautious due to tariff uncertainty.
The U.S. mental health treatment market is valued at $118 billion and is projected to grow significantly through 2030, driven by increased awareness, technology integration, and rising mental illness prevalence affecting 61 million Americans. The sector faces challenges including a shortage of mental health professionals and access gaps, while teletherapy and mental health apps have created a $2 billion market segment. Major players include facility operators like Acadia Healthcare and Universal Health Services, alongside digital platforms such as Lyra Health, Spring Health, Headspace, Calm, Talkspace, and BetterHelp.
Engine Capital Management invested $64 million in Acadia Healthcare, acquiring 2.6 million shares despite the stock being down 63% over the past year, signaling potential long-term value in behavioral healthcare services.
Law Offices of Howard G. Smith is investigating potential securities law violations by Acadia Healthcare Company after the company disclosed higher-than-expected litigation expenses and reduced financial guidance, causing stock price decline.
Acadia Healthcare disclosed higher anticipated patient-related litigation expenses, reducing its full-year 2025 Adjusted EBITDA guidance and causing a significant stock price drop of up to 23%.
U.S. stock futures rose on Wednesday, with markets anticipating a potential Federal Reserve interest rate cut. Key companies like Marvell Technology and Salesforce reported earnings, while economic data releases are expected throughout the day.
The global dialectical behavior therapy market is projected to grow from USD 1.31 billion in 2025 to USD 3.29 billion by 2034, driven by rising mental health awareness, technological advancements, and expanding digital therapy platforms.
The global cognitive behavioral therapy (CBT) market is expected to expand from $7.77 billion in 2024 to $34.25 billion by 2034, driven by rising mental health awareness, technological advancements, and increasing demand for mental health treatments.
